Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Chronic Diseases
4.2.2 Increasing Demand for Blood Transfusions and IV infusions
4.3 Market Restraints
4.3.1 Lack of Product Innovation and Development
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type of Needle Gauges
5.1.1 21G butterfly needles
5.1.2 23G butterfly needles
5.1.3 Other Types of Needle Gauges
5.2 By Aplication
5.2.1 Venipuncture
5.2.2 Medicine Delivery
5.2.3 Blood Transfusion
5.2.4 IV Infusion
5.3 By End-User
5.3.1 Hospitals
5.3.2 Blood Banks
5.3.3 Pathology Labs
5.3.4 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 United Kingdom
5.4.2.2 France
5.4.2.3 Germany
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 India
5.4.3.2 China
5.4.3.3 Japan
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 OMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Cardinal Health
6.1.2 Terumo Corporation
6.1.3 Bionic Medizintechnik
6.1.4 BioMatrix S.r.l.
6.1.5 Nipro Corporation
6.1.6 Medline Industries
6.1.7 Braun Melsungen AG
6.1.8 Becton, Dickinson and Company
6.1.9 Kawasumi Laboratories
6.1.10 ICU Medical, Inc. (Smiths Medical)


7 MARKET OPPORTUNITIES AND FUTURE TRENDS